Showing results (391-400 of 671) with videos related to

Sort By:
Pageof 68
BMC Genomics|December 10, 2014
Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transitionSteven H Lin, Jing Wang, Pierre Saintigny, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2018
Validation of the 12-gene Predictive Signature for Adjuvant Chemotherapy Response in Lung CancerYang Xie, Wei Lu, Shidan Wang, et al.
The Journal of Pathology|May 15, 2018
A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patientsElena Martínez-Terroba, Carmen Behrens, Fernando J de Miguel, et al.
Journal of Bronchology & Interventional Pulmonology|August 3, 2019
Pleural Fluid Cytokine Levels at Baseline and Over Time are Associated With Time to IPC Removal: An Exploratory StudyHoriana B Grosu, Wei Lu, David E Ost, et al.
Clinical Lung Cancer|April 14, 2020
Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant ChemotherapyAnnikka Weissferdt, Apar Pataer, Ara A Vaporciyan, et al.
Nature Cancer|January 10, 2024
LncRNA Malat1 suppresses pyroptosis and T cell-mediated killing of incipient metastatic cellsDhiraj Kumar, Sreeharsha Gurrapu, Yan Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 14, 2018
Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancersMasanori Kawakami, Lisa Maria Mustachio, Lin Zheng, et al.
The Oncologist|October 6, 2022
Mutation-Agnostic Detection of Colorectal Cancer Using Liquid Biopsy-Based Methylation-Specific SignaturesMohamed A Gouda, Dzifa Y Duose, Morten Lapin, et al.
BMC Genomics|October 8, 2015
Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterationsAnder Aramburu, Isabel Zudaire, María J Pajares, et al.
Cancer Research|September 10, 2009
Elevated epithelial insulin-like growth factor expression is a risk factor for lung cancer developmentWoo-Young Kim, Quanri Jin, Seung-Hyun Oh, et al.
Pageof 68